Literature DB >> 15456404

2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells.

Maiko Gokoh1, Seishi Kishimoto, Saori Oka, Masahiro Mori, Keizo Waku, Yoshio Ishima, Takayuki Sugiura.   

Abstract

Delta9-Tetrahydrocannabinol, a major psychoactive constituent of marijuana, interacts with specific receptors, i.e. the cannabinoid receptors, thereby eliciting a variety of pharmacological responses. To date, two types of cannabinoid receptors have been identified: the CB1 receptor, which is abundantly expressed in the nervous system, and the CB2 receptor, which is predominantly expressed in the immune system. Previously, we investigated in detail the structure-activity relationship of various cannabinoid receptor ligands and found that 2-AG (2-arachidonoylglycerol) is the most efficacious agonist. We have proposed that 2-AG is the true natural ligand for both the CB1 and CB2 receptors. Despite the potential physiological importance of 2-AG, not much information is available concerning its biological activities towards mammalian tissues and cells. In the present study, we examined the effect of 2-AG on morphology as well as the actin filament system in differentiated HL-60 cells, which express the CB2 receptor. We found that 2-AG induces rapid morphological changes such as the extension of pseudopods. We also found that it provokes a rapid actin polymerization in these cells. Actin polymerization induced by 2-AG was abolished when cells were treated with SR144528, a CB2 receptor antagonist, and pertussis toxin, suggesting that the response was mediated by the CB2 receptor and G(i/o). A phosphoinositide 3-kinase, Rho family small G-proteins and a tyrosine kinase were also suggested to be involved. Reorganization of the actin filament system is known to be indispensable for a variety of cellular events; it is possible that 2-AG plays physiologically essential roles in various inflammatory cells and immune-competent cells by inducing a rapid actin rearrangement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15456404      PMCID: PMC1134878          DOI: 10.1042/BJ20041163

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  53 in total

Review 1.  Small GTP-binding proteins.

Authors:  Y Takai; T Sasaki; T Matozaki
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

2.  Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.

Authors:  W Gonsiorek; C Lunn; X Fan; S Narula; D Lundell; R W Hipkin
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

3.  Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells.

Authors:  T Sugiura; S Kondo; S Kishimoto; T Miyashita; S Nakane; T Kodaka; Y Suhara; H Takayama; K Waku
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

4.  Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds.

Authors:  T Sugiura; T Kodaka; S Nakane; T Miyashita; S Kondo; Y Suhara; H Takayama; K Waku; C Seki; N Baba; Y Ishima
Journal:  J Biol Chem       Date:  1999-01-29       Impact factor: 5.157

Review 5.  Endogenous cannabinoid signaling.

Authors:  D Piomelli; M Beltramo; A Giuffrida; N Stella
Journal:  Neurobiol Dis       Date:  1998-12       Impact factor: 5.996

Review 6.  Cannabinoid receptors and the regulation of immune response.

Authors:  E V Berdyshev
Journal:  Chem Phys Lipids       Date:  2000-11       Impact factor: 3.329

Review 7.  2-Arachidonoylglycerol and the cannabinoid receptors.

Authors:  T Sugiura; K Waku
Journal:  Chem Phys Lipids       Date:  2000-11       Impact factor: 3.329

Review 8.  Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.

Authors:  C J Hillard
Journal:  Prostaglandins Other Lipid Mediat       Date:  2000-04       Impact factor: 3.072

9.  2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice.

Authors:  R Gallily; A Breuer; R Mechoulam
Journal:  Eur J Pharmacol       Date:  2000-10-06       Impact factor: 4.432

10.  Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1.

Authors:  Y Chen; R M McCarron; Y Ohara; J Bembry; N Azzam; F A Lenz; E Shohami; R Mechoulam; M Spatz
Journal:  Circ Res       Date:  2000-08-18       Impact factor: 17.367

View more
  11 in total

Review 1.  Cannabinoid receptors and endocannabinoids: evidence for new players.

Authors:  Ken Mackie; Nephi Stella
Journal:  AAPS J       Date:  2006-04-28       Impact factor: 4.009

Review 2.  Roles and mechanisms of the CD38/cyclic adenosine diphosphate ribose/Ca(2+) signaling pathway.

Authors:  Wenjie Wei; Richard Graeff; Jianbo Yue
Journal:  World J Biol Chem       Date:  2014-02-26

Review 3.  Cannabinoids and cancer: pros and cons of an antitumour strategy.

Authors:  Maurizio Bifulco; Chiara Laezza; Simona Pisanti; Patrizia Gazzerro
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

Review 4.  Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists.

Authors:  C A Lunn; E-P Reich; J S Fine; B Lavey; J A Kozlowski; R W Hipkin; D J Lundell; L Bober
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

5.  Blockade of cannabinoid receptors reduces inflammation, leukocyte accumulation and neovascularization in a model of sponge-induced inflammatory angiogenesis.

Authors:  Rodrigo Guabiraba; Remo C Russo; Amanda M Coelho; Mônica A N D Ferreira; Gabriel A O Lopes; Ariane K C Gomes; Silvia P Andrade; Luciola S Barcelos; Mauro M Teixeira
Journal:  Inflamm Res       Date:  2013-05-31       Impact factor: 4.575

Review 6.  Downstream effects of endocannabinoid on blood cells: implications for health and disease.

Authors:  Valeria Gasperi; Daniela Evangelista; Isabella Savini; Domenico Del Principe; Luciana Avigliano; Mauro Maccarrone; Maria Valeria Catani
Journal:  Cell Mol Life Sci       Date:  2015-05-10       Impact factor: 9.261

Review 7.  The CB2 receptor and its role as a regulator of inflammation.

Authors:  Caroline Turcotte; Marie-Renée Blanchet; Michel Laviolette; Nicolas Flamand
Journal:  Cell Mol Life Sci       Date:  2016-07-11       Impact factor: 9.261

Review 8.  The Immune Endocannabinoid System of the Tumor Microenvironment.

Authors:  Melanie Kienzl; Julia Kargl; Rudolf Schicho
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

Review 9.  The Interplay between the Immune and the Endocannabinoid Systems in Cancer.

Authors:  Mariantonia Braile; Simone Marcella; Gianni Marone; Maria Rosaria Galdiero; Gilda Varricchi; Stefania Loffredo
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

10.  Expression and Functions of the CB2 Receptor in Human Leukocytes.

Authors:  Mélissa Simard; Volatiana Rakotoarivelo; Vincenzo Di Marzo; Nicolas Flamand
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.